Israeli Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

G.F.C Green Fields Capital

Market Cap: ₪121.3m

Does not have significant operations.

Purple Biotech

Market Cap: ₪15.9m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Smart Agro -

Market Cap: ₪9.4m

Focuses on the research and development in the field of agricultural technology in Israel.

PlantArc Bio

Market Cap: ₪6.9m

Operates as an Ag-Bio company for the crop protection and yield enhancement.

Can-Fite BioPharma

Market Cap: ₪47.3m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

Seach Medical Group

Market Cap: ₪90.9m

Manufactures and sells medicinal cannabis products worldwide.

BioLineRx

Market Cap: ₪53.7m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Rekah Pharmaceutical Industry

Market Cap: ₪126.1m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

HBL - Hadasit Bio-Holdings

Market Cap: ₪6.1m

Operates in the biotechnology industry in Israel.

Matricelf

Market Cap: ₪78.4m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

BioLight Life Sciences

Market Cap: ₪18.8m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

Grace Breeding

Market Cap: ₪82.7m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

Evogene

Market Cap: ₪33.8m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

InterCure

Market Cap: ₪233.3m

Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.